Bosh sahifa600664 ā¢ SHA
add
Harbin Pharmaceutical Group Co., Ltd.
Yopilish kursi
3,64Ā Ā„
Yillik diapazon
2,41Ā Ā„ - 4,13Ā Ā„
Bozor kapitalizatsiyasi
9,49Ā mlrd CNY
OŹ»rtacha hajm
35,52Ā mln
Narx/foyda
16,19
Dividend daromadliligi
-
Asosiy maydon
SHA
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(CNY) | iyn, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 4,00Ā mlrd | 6,05% |
Joriy xarajat | 977,13Ā mln | 23,80% |
Sof foyda | 166,64Ā mln | 175,81% |
Sof foyda marjasi | 4,17 | 160,62% |
Har bir ulushga tushum | ā | ā |
EBITDA | 274,38Ā mln | 50,36% |
Amaldagi soliq stavkasi | 22,99% | ā |
Balans
Jami aktivlari
Jami passivlari
(CNY) | iyn, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 3,18Ā mlrd | 22,51% |
Jami aktivlari | 14,24Ā mlrd | 3,68% |
Jami passivlari | 8,48Ā mlrd | -0,98% |
Umumiy kapital | 5,76Ā mlrd | ā |
Tarqatilgan aksiyalar | 2,52Ā mlrd | ā |
Narxi/balansdagi bahosi | 1,82 | ā |
Aktivlardan daromad | 3,80% | ā |
Kapitaldan daromad | 7,00% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
(CNY) | iyn, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | 166,64Ā mln | 175,81% |
Operatsiyalardan naqd pul | 344,42Ā mln | -1,27% |
Sarmoyadan naqd pul | -15,62Ā mln | -70,10% |
Moliyadan naqd pul | 15,19Ā mln | 115,53% |
Naqd pulning sof oŹ»zgarishi | 344,23Ā mln | 40,80% |
BoŹ»sh pul | 377,94Ā mln | 6,99% |
Haqida
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Tashkil etilgan
1988
Sayt
Xodimlar soni
9Ā 853